The brokerage currently has a $6.00 price target on the biotechnology company’s stock. BCRX has been the subject of a number of other reports.
10
Dec
Leave a Reply
You must be logged in to post a comment.
The brokerage currently has a $6.00 price target on the biotechnology company’s stock. BCRX has been the subject of a number of other reports.
You must be logged in to post a comment.